STOCK TITAN

LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
LeMaitre Vascular, Inc. (LMAT) is set to announce its fourth quarter 2023 financial results on February 27, 2024, with a conference call scheduled to discuss the results, business highlights, and company outlook.
Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com


LeMaitre Vascular will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market close.

The conference call to discuss the results, business highlights, and company outlook is scheduled for 5:00 PM ET on the same day.

Access to the live call is available by registering online, and the audio webcast can be accessed live or via replay through a webcast at www.lemaitre.com/investor.
Lemaitre Vascular Inc

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Burlington

About LMAT

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.